Cargando…

Supplementation with a selective amino acid formula ameliorates muscular dystrophy in mdx mice

Duchenne muscular dystrophy (DMD) is one of the most common and severe forms of muscular dystrophy. Oxidative myofibre content, muscle vasculature architecture and exercise tolerance are impaired in DMD. Several studies have demonstrated that nutrient supplements ameliorate dystrophic features, ther...

Descripción completa

Detalles Bibliográficos
Autores principales:	Banfi, Stefania, D’Antona, Giuseppe, Ruocco, Chiara, Meregalli, Mirella, Belicchi, Marzia, Bella, Pamela, Erratico, Silvia, Donato, Elisa, Rossi, Fabio, Bifari, Francesco, Lonati, Caterina, Campaner, Stefano, Nisoli, Enzo, Torrente, Yvan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6168581/ https://www.ncbi.nlm.nih.gov/pubmed/30279586 http://dx.doi.org/10.1038/s41598-018-32613-w

Ejemplares similares

Blockade of IGF2R improves muscle regeneration and ameliorates Duchenne muscular dystrophy
por: Bella, Pamela, et al.
Publicado: (2019)

Influence of Immune Responses in Gene/Stem Cell Therapies for Muscular Dystrophies
por: Farini, Andrea, et al.
Publicado: (2014)

Autologous intramuscular transplantation of engineered satellite cells induces exosome-mediated systemic expression of Fukutin-related protein and rescues disease phenotype in a murine model of limb-girdle muscular dystrophy type 2I
por: Frattini, Paola, et al.
Publicado: (2017)

Preliminary Evidences of Safety and Efficacy of Flavonoids- and Omega 3-Based Compound for Muscular Dystrophies Treatment: A Randomized Double-Blind Placebo Controlled Pilot Clinical Trial
por: Sitzia, Clementina, et al.
Publicado: (2019)

Correlation of Circulating CD133+ Progenitor Subclasses with a Mild Phenotype in Duchenne Muscular Dystrophy Patients
por: Marchesi, Chiara, et al.
Publicado: (2008)

Effects of rituximab in two patients with dysferlin-deficient muscular dystrophy
por: Lerario, Alberto, et al.
Publicado: (2010)

Duchenne muscular dystrophy caused by a frame-shift mutation in the acceptor splice site of intron 26
por: Meregalli, Mirella, et al.
Publicado: (2016)

Improvement of Endurance of DMD Animal Model Using Natural Polyphenols
por: Sitzia, Clementina, et al.
Publicado: (2015)

A balanced formula of essential amino acids promotes brain mitochondrial biogenesis and protects neurons from ischemic insult
por: Ragni, Maurizio, et al.
Publicado: (2023)

Clinical Applications of Mesenchymal Stem Cells in Chronic Diseases
por: Farini, Andrea, et al.
Publicado: (2014)

Stem Cell Tracking by Nanotechnologies
por: Villa, Chiara, et al.
Publicado: (2010)

Effective high-throughput isolation of enriched platelets and circulating pro-angiogenic cells to accelerate skin-wound healing
por: Erratico, Silvia, et al.
Publicado: (2022)

Identification of a putative pathway for the muscle homing of stem cells in a muscular dystrophy model
por: Torrente, Yvan, et al.
Publicado: (2003)

Branched-chain amino acids, mitochondrial biogenesis, and healthspan: an evolutionary perspective
por: Valerio, Alessandra, et al.
Publicado: (2011)

A Special Amino-Acid Formula Tailored to Boosting Cell Respiration Prevents Mitochondrial Dysfunction and Oxidative Stress Caused by Doxorubicin in Mouse Cardiomyocytes
por: Tedesco, Laura, et al.
Publicado: (2020)

Nutrients and Muscle Disease
por: Nisoli, Enzo, et al.
Publicado: (2015)

uPA deficiency exacerbates muscular dystrophy in MDX mice
por: Suelves, Mònica, et al.
Publicado: (2007)

uPA deficiency exacerbates muscular dystrophy in MDX mice
por: Suelves, Mònica, et al.
Publicado: (2007)

Social stress is lethal in the mdx model of Duchenne muscular dystrophy
por: Razzoli, Maria, et al.
Publicado: (2020)

Generation of the Becker muscular dystrophy patient derived induced pluripotent stem cell line carrying the DMD splicing mutation c.1705-8 T>C.
por: Rovina, Davide, et al.
Publicado: (2020)

The Immune System in Duchenne Muscular Dystrophy Pathogenesis
por: Tripodi, Luana, et al.
Publicado: (2021)

Role of Immunoglobulins in Muscular Dystrophies and Inflammatory Myopathies
por: Farini, Andrea, et al.
Publicado: (2021)

Biochemical and Functional Comparisons of mdx and Sgcg (−/−) Muscular Dystrophy Mouse Models
por: Roberts, Nathan W., et al.
Publicado: (2015)

Lack of miR-378 attenuates muscular dystrophy in mdx mice
por: Podkalicka, Paulina, et al.
Publicado: (2020)

Novel insight into stem cell trafficking in dystrophic muscles
por: Farini, Andrea, et al.
Publicado: (2012)

The involvement of microRNAs in neurodegenerative diseases
por: Maciotta, Simona, et al.
Publicado: (2013)

Role of Insulin-Like Growth Factor Receptor 2 across Muscle Homeostasis: Implications for Treating Muscular Dystrophy
por: Torrente, Yvan, et al.
Publicado: (2020)

Defective dystrophic thymus determines degenerative changes in skeletal muscle
por: Farini, Andrea, et al.
Publicado: (2021)

Amino acid supplements and metabolic health: a potential interplay between intestinal microbiota and systems control
por: Bifari, Francesco, et al.
Publicado: (2017)

A nitric oxide synthase transgene ameliorates muscular dystrophy in mdx mice
por: Wehling, Michelle, et al.
Publicado: (2001)

Arginine Metabolism by Macrophages Promotes Cardiac and Muscle Fibrosis in mdx Muscular Dystrophy
por: Wehling-Henricks, Michelle, et al.
Publicado: (2010)

Dietary supplementation with essential amino acids boosts the beneficial effects of rosuvastatin on mouse kidney
por: Corsetti, Giovanni, et al.
Publicado: (2014)

PTX3 Predicts Myocardial Damage and Fibrosis in Duchenne Muscular Dystrophy
por: Farini, Andrea, et al.
Publicado: (2020)

In vivo MRI Characterization of Progressive Cardiac Dysfunction in the mdx Mouse Model of Muscular Dystrophy
por: Stuckey, Daniel J., et al.
Publicado: (2012)

Whole Body Periodic Acceleration Is an Effective Therapy to Ameliorate Muscular Dystrophy in mdx Mice
por: Altamirano, Francisco, et al.
Publicado: (2014)

Ventilatory Chemosensory Drive Is Blunted in the mdx Mouse Model of Duchenne Muscular Dystrophy (DMD)
por: Mosqueira, Matias, et al.
Publicado: (2013)

Muscular dystrophy in the mdx mouse is a severe myopathy compounded by hypotrophy, hypertrophy and hyperplasia
por: Duddy, William, et al.
Publicado: (2015)

Naproxcinod shows significant advantages over naproxen in the mdx model of Duchenne Muscular Dystrophy
por: Miglietta, Daniela, et al.
Publicado: (2015)

Comparison of Experimental Protocols of Physical Exercise for mdx Mice and Duchenne Muscular Dystrophy Patients
por: Hyzewicz, Janek, et al.
Publicado: (2015)

miR-146a deficiency does not aggravate muscular dystrophy in mdx mice
por: Bronisz-Budzyńska, Iwona, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_noq4slvqn0eo62sf8qfd5mnqai